Symrise (FRA:SY1 – Get Rating) has been assigned a €127.00 ($136.56) price target by analysts at The Goldman Sachs Group in a research report issued on Wednesday, Borsen Zeitung reports. The Goldman Sachs Group’s target price would indicate a potential upside of 19.70% from the stock’s current price.
SY1 has been the subject of a number of other reports. Warburg Research set a €116.00 ($124.73) target price on shares of Symrise in a report on Tuesday, March 15th. UBS Group set a €130.00 ($139.78) price objective on shares of Symrise in a research report on Monday, April 4th. Deutsche Bank Rese… set a €138.00 ($148.39) price objective on shares of Symrise in a research report on Monday, March 28th. Berenberg Bank set a €119.00 ($127.96) target price on shares of Symrise in a research note on Thursday, March 24th. Finally, Baader Bank set a €125.00 ($134.41) price objective on shares of Symrise in a research note on Friday, April 8th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Symrise currently has a consensus rating of “Hold” and a consensus target price of €119.97 ($129.00).
Shares of SY1 stock opened at €106.10 ($114.09) on Wednesday. Symrise has a 12 month low of €56.96 ($61.25) and a 12 month high of €73.48 ($79.01). The firm has a fifty day moving average price of €106.41 and a 200 day moving average price of €115.10.
Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.
- Las Vegas Sands Stock Could be a Winning Bet Down Here
- Newmont Corporation is the Same as It’s Always Been Which is Why It’s a Buy
- The Sherwin-Williams Company Bottoms Above Institutional Support
- Simpson Manufacturing Co. Hits The Nail On The Head, Again
- What To Make Of Activision Blizzard (NASDAQ: ATVI)
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.